Sanofi SA Company Profile (EPA:SAN)

About Sanofi SA

Sanofi SA logoSanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation. Its pharmaceuticals portfolio consists of products and a range of prescription medicines, generic medicines and consumer health products. The Vaccines segment is dedicated to vaccines, including research, development, production and marketing. The Animal Health segment includes the research, development, production and marketing activities of Merial, which offers a range of medicines and vaccines for a range of animal species. It also operates in the Other segment, which includes the effects of retained commitments in respect of divested activities.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: EPA
  • Symbol: SAN
  • CUSIP:
Key Metrics:
  • Previous Close: $68.03
  • 50 Day Moving Average: $26.02
  • 200 Day Moving Average: $25.74
  • Trailing P/E Ratio: 21.15
  • P/E Growth: 0.00
  • Market Cap: $87.55B
Additional Links:

Analyst Ratings

Consensus Ratings for Sanofi SA (EPA:SAN) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.35)
Consensus Price Target: €86.76

Analysts' Ratings History for Sanofi SA (EPA:SAN)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016JPMorgan Chase & Co.Set Price TargetSell€71.00View Rating Details
9/14/2016BNP ParibasSet Price TargetNeutral€78.00View Rating Details
9/13/2016Jefferies GroupSet Price TargetNeutral€76.00View Rating Details
9/8/2016Berenberg BankSet Price TargetBuy€93.00View Rating Details
8/11/2016Kepler Capital MarketsSet Price TargetBuy€89.00View Rating Details
8/1/2016Societe GeneraleSet Price TargetBuy€100.00View Rating Details
6/30/2016Independent Research GmbHSet Price TargetNeutral€77.00View Rating Details
6/9/2016Baader BankSet Price TargetNeutral€78.00View Rating Details
5/12/2016Barclays PLCSet Price TargetBuy€84.00View Rating Details
5/3/2016HSBCSet Price TargetNeutral€81.00View Rating Details
4/25/2016Morgan StanleySet Price TargetNeutral€90.00View Rating Details
3/14/2016Goldman Sachs Group Inc.Set Price TargetNeutral€80.00View Rating Details
2/9/2016S&P Equity ResearchSet Price TargetBuy€85.00View Rating Details
11/30/2015Deutsche Bank AGSet Price TargetBuy€103.00View Rating Details
11/9/2015Sanford C. BernsteinSet Price TargetNeutral€91.00View Rating Details
10/30/2015Credit Suisse Group AGSet Price TargetBuy€100.00View Rating Details
10/29/2015Citigroup Inc.Set Price TargetNeutral€99.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Sanofi SA (EPA:SAN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sanofi SA (EPA:SAN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sanofi SA (EPA:SAN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sanofi SA (EPA:SAN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Sanofi SA (EPA:SAN)
DateHeadline
News IconWill Sanofi SA (ADR) (SNY) Lead the Zika Vaccine Manufacturing? - Smаrt Stоck Nеws (EPA:SAN)
www.smartstocknews.com - September 28 at 12:24 PM
thecountrycaller.com logoCan This be Sanofi SA's (SNY) Biggest Win In 2017? - TCC (EPA:SAN)
www.thecountrycaller.com - September 28 at 12:24 PM
marketexclusive.com logoSanofi SA (NYSE:SNY) Gets BARDA Funding For Zika Trial - Market Exclusive (EPA:SAN)
marketexclusive.com - September 28 at 12:24 PM
News IconFDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Review (EPA:SAN)
www.advfn.com - September 27 at 7:03 PM
reuters.com logoSanofi gets $43 million U.S. funding to spur Zika vaccine development (EPA:SAN)
www.reuters.com - September 27 at 7:03 PM
finance.yahoo.com logoEU mergers and takeovers (Sept 27) (EPA:SAN)
finance.yahoo.com - September 27 at 7:03 PM
News IconSanofi gets US$43 million US funding to spur Zika vaccine development (EPA:SAN)
www.channelnewsasia.com - September 27 at 11:47 AM
marketexclusive.com logoSanofi SA (NYSE:SNY) Gets BARDA Funding For Zika Trial (EPA:SAN)
marketexclusive.com - September 27 at 11:47 AM
foxnews.com logoSanofi gets $43M US funding to spur Zika vaccine development (EPA:SAN)
www.foxnews.com - September 27 at 11:47 AM
reuters.com logoSanofi gets $43 mln US funding to spur Zika vaccine development - Reuters (EPA:SAN)
www.reuters.com - September 26 at 7:12 PM
nasdaq.com logoFDA Accepts Sanofi''s, Regeneron''s Dermatitis Treatment for Priority Review - Nasdaq (EPA:SAN)
www.nasdaq.com - September 26 at 8:04 AM
finance.yahoo.com logoSanofi may win U.S. approval of $3 billion eczema drug by March (EPA:SAN)
finance.yahoo.com - September 26 at 8:04 AM
bizjournals.com logo​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme (EPA:SAN)
www.bizjournals.com - September 26 at 8:04 AM
finance.yahoo.com logoUnitedHealth trims drug coverage, including Sanofi insulin - Yahoo Finance (EPA:SAN)
finance.yahoo.com - September 22 at 6:52 PM
News IconEpiPen’s CEO in the Hot Seat Over Price Spikes (EPA:SAN)
www.iwf.org - September 22 at 11:58 AM
finance.yahoo.com logoHard to swallow: emerging markets get tougher for drugmakers (EPA:SAN)
in.finance.yahoo.com - September 22 at 11:58 AM
News IconSanofi, Vinapharm deal to open Vietnam market (EPA:SAN)
www.bioworld.com - September 21 at 6:45 PM
News IconUnitedHealth trims drug coverage, including Sanofi insulin (EPA:SAN)
www.channelnewsasia.com - September 21 at 6:45 PM
News IconBank of America Corp (NYSE:BAC) & Sanofi SA (ADR) (NYSE:SNY) UPDATE ON U.S STOCKS : 16 SEP 2016 - Money News (EPA:SAN)
www.newsismoney.com - September 20 at 12:27 PM
News IconSanofi Files U.S. Suit Against Merck on Patent Infringements (EPA:SAN)
www.advfn.com - September 19 at 7:05 PM
News IconSanofi Files Suit Against Merck (EPA:SAN)
ih.advfn.com - September 19 at 7:05 PM
wsj.com logoSanofi Files Suit Against Merck, Claiming Patent Infringements (EPA:SAN)
www.wsj.com - September 19 at 7:05 PM
finance.yahoo.com logoSanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap (EPA:SAN)
finance.yahoo.com - September 19 at 7:05 PM
News IconInvestor's Alert: Sanofi SA (ADR)(NYSE:SNY), General Dynamics Corporation(NYSE:GD), Scripps Networks Interactive ... - NYSE Journal (press release) (EPA:SAN)
stockznews.com - September 19 at 11:44 AM
wsj.com logoSanofi Files Suit Against Merck, Claiming Patent Infringements - Wall Street Journal (EPA:SAN)
www.wsj.com - September 19 at 11:44 AM
thestreet.com logoSanofi Fighting a Losing Battle Sues Merck for Alleged Patent Infrigement (EPA:SAN)
www.thestreet.com - September 19 at 11:44 AM
wsj.com logo[$$] Sanofi Files Suit Against Merck (EPA:SAN)
www.wsj.com - September 19 at 11:44 AM
fool.com logo6 Flu Season Facts You Probably Don't Know (EPA:SAN)
www.fool.com - September 17 at 11:37 AM
reuters.com logoFirst Tylenol bellwether put on hold following settlement talks (EPA:SAN)
www.reuters.com - September 16 at 6:56 PM
reuters.com logoNew Mexico AG sues Bristol-Myers, Sanofi over blood thinner - Reuters (EPA:SAN)
www.reuters.com - September 16 at 10:43 AM
News IconKellogg Company (NYSE:K) & Sanofi SA (ADR) (NYSE:SNY) UPDATE ON U.S STOCKS : 15 SEP 2016 - Money News (EPA:SAN)
www.newsismoney.com - September 16 at 10:43 AM
uk.finance.yahoo.com logoTreatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials (EPA:SAN)
uk.finance.yahoo.com - September 16 at 10:43 AM
finance.yahoo.com logoSanofi: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme's Lemtrada® (alemtuzumab) in Clinical Trials (EPA:SAN)
finance.yahoo.com - September 16 at 10:43 AM
marketrealist.com logoWill Sanofi See More Growth from Its Blockbuster Insulin Drug? (EPA:SAN)
marketrealist.com - September 15 at 10:46 AM
marketrealist.com logoSanofi’s Rare Disease Franchise Continues to Be a Revenue Boon (EPA:SAN)
marketrealist.com - September 15 at 10:46 AM
News IconSanofi Pasteur SA Pipeline Review, Industry Study, Research and Clinical trial 2016 – 2020 (EPA:SAN)
www.medgadget.com - September 14 at 11:32 AM
marketexclusive.com logoSanofi SA (NYSE:SNY) Keeps Tab Of The Launch Of Dengvaxia (EPA:SAN)
marketexclusive.com - September 13 at 12:03 PM
marketwatch.com logoSanofi, Alphabet's Verily Life create diabetes JV (EPA:SAN)
www.marketwatch.com - September 12 at 6:47 PM
seekingalpha.com logoAvoid Sanofi Bonds (EPA:SAN)
seekingalpha.com - September 12 at 6:47 PM
wsj.com logoGoogle Parent and Sanofi Name Diabetes Joint Venture Onduo (EPA:SAN)
www.wsj.com - September 12 at 11:53 AM
News IconGoogle Parent and Sanofi Name Diabetes Joint Venture Onduo--2nd Update (EPA:SAN)
ih.advfn.com - September 12 at 11:53 AM
investors.com logoSanofi and Google form joint venture to tackle diabetes (EPA:SAN)
www.proactiveinvestors.com - September 12 at 11:53 AM
thecountrycaller.com logoSanofi SA (ADR) & Alphabet Inc's Verily Life Sciences To Bet Big On Diabetes (EPA:SAN)
www.thecountrycaller.com - September 12 at 11:53 AM
News IconLexicon's sotagliflozin successful in late-stage study; shares up 18% premarket (EPA:SAN)
magseriesusa.net - September 11 at 11:06 AM
bidnessetc.com logoLexicon Pharmaceuticals, Inc, Sanofi SA Collab Sotagliflozin Outshines in Phase 3 Diabetes Trial - Bidness ETC (EPA:SAN)
www.bidnessetc.com - September 9 at 11:55 AM
News Icon“Getting Paid to Borrow” (EPA:SAN)
husbandfatherson.wordpress.com - September 8 at 10:59 AM
News IconCambridge biotech firm Moderna wins Zika vaccine grant (EPA:SAN)
www.bostonglobe.com - September 7 at 7:17 PM
wsj.com logoThe Morning Ledger: Companies Get in on Negative-Interest Game (EPA:SAN)
blogs.wsj.com - September 7 at 7:17 PM
News IconWeak Dollar Wednesday – Markets Propped Up in Grand Illusion (EPA:SAN)
investmentwatchblog.com - September 7 at 7:17 PM
News IconCompanies get paid to sell bonds as borrowing binge resumes (EPA:SAN)
www.pionline.com - September 7 at 7:17 PM

Social


Last Updated on 9/29/2016 by MarketBeat.com Staff